Publicaciones (71) Publicaciones de SILVIA ORTEGA GUTIÉRREZ

2024

  1. A new fluorescent probe for the visualization of progerin

    Bioorganic Chemistry, Vol. 142

2023

  1. New Pharmacological Approaches for Rare Diseases

    International Journal of Molecular Sciences

2022

  1. New Trends in Aging Drug Discovery

    Biomedicines, Vol. 10, Núm. 8

  2. Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice

    Journal of Medicinal Chemistry, Vol. 65, Núm. 16, pp. 10956-10974

2021

  1. Chemistry for the Identification of Therapeutic Targets: Recent Advances and Future Directions

    European Journal of Organic Chemistry, Vol. 2021, Núm. 9, pp. 1307-1320

  2. Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson-Gilford Progeria Syndrome

    ACS Central Science, Vol. 7, Núm. 8, pp. 1300-1310

  3. Small-molecule therapeutic perspectives for the treatment of progeria

    International Journal of Molecular Sciences, Vol. 22, Núm. 13

2020

  1. A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration

    Journal of Medicinal Chemistry, Vol. 63, Núm. 5, pp. 2372-2390

  2. Serum endocannabinoid levels in suicide attempters: A pilot study

    European Neuropsychopharmacology, Vol. 40, pp. 52-60

2019

  1. A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia

    Journal of Medicinal Chemistry, Vol. 62, Núm. 13, pp. 6035-6046

  2. Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons

    Neuropharmacology, Vol. 150, pp. 134-144

  3. Blocking Ras inhibition as an antitumor strategy

    Seminars in Cancer Biology, Vol. 54, pp. 91-100

2018

  1. Development of a Fluorescent Bodipy Probe for Visualization of the Serotonin 5-HT 1A Receptor in Native Cells of the Immune System

    Bioconjugate Chemistry, Vol. 29, Núm. 6, pp. 2021-2027

  2. 2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs

    GLIA, Vol. 66, Núm. 7, pp. 1447-1463

  3. A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB1 in Human Blood and Tonsil Immune System Cells

    Bioconjugate Chemistry, Vol. 29, Núm. 2, pp. 382-389

  4. Chapter 9: Fluorescent Probes in Medicinal Chemistry

    RSC Drug Discovery Series (Royal Society of Chemistry), pp. 239-262

  5. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination

    Biochemical Pharmacology, Vol. 157, pp. 189-201

  6. Monoacylglycerol lipase (MAGL) as a promising therapeutic target

    Biochemical Pharmacology, Vol. 157, pp. 18-32

  7. Unique pharmacological properties of serotoninergic G-protein coupled receptors from cestodes

    PLoS Neglected Tropical Diseases, Vol. 12, Núm. 2

2017

  1. 2-arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination

    Journal of Neuroscience, Vol. 37, Núm. 35, pp. 8385-8398